Cytiva broadens Xcellerex X-platform to include 500 L and 2000 L bioreactors

28 Mar 2025

As researchers and scientists work to discover the next generation of advanced therapeutics, Cytiva is expanding the Xcellerex X-platform portfolio to meet their growing needs with the addition of 500 L and 2000 L bioreactors. The X-platform is a reliable and flexible single-use system designed to increase operational efficiencies and production capacity, while helping to lower costs, reduce risks, and bring life-changing therapeutics to the next clinical milestone faster.

Why the X-Platform is different

The X-platform bioreactor portfolio was designed to meet the process needs of early-stage clinical researchers all the way through to commercial manufacturing. Customers can easily scale from 50L to 2 000L and while also reducing the time spent optimizing. Additional features include:

An infrared-based camera that provides accurate detection of foam appearing in the process, allowing for early, automated intervention.
Working height management of exhaust filters and heaters designed to simplify filter changes and minimize the need for manipulations at height.
Quick and easy “off-the shelf” bag configuration and installation which helps reduce the risk of error. A rigid base construction ensures consistent installation of the single-use bioreactor bag, minimizing the risk of batch failure

Ludovic Brellier, President of Hardware Solutions, Cytiva, says, “Our customers need speed and flexibility to develop advanced therapeutics. The expansion of Cytiva’s Xcellerex X-platform portfolio and its additional features will help our customers scale their operations more efficiently. The design and functionality of the hardware, biocontainers and software will allow our customers to safely manufacture life changing therapeutics faster.”